This page last updated: 12/05/2022 13:15
- Monovalent: 0
- Bivalent (ages 6 and up): 170
- Monovalent: 0
- Bivalent (ages 12 and up): 0
- Bivalent (ages 5 to 11): 0
- Influenza quadrivalent
- Standard dose: 2
- High dose/adjuvanted: 0
- Paxlovid antiviral: 30 courses
News and Updates
Influenza vaccine are administered weekly, Monday through Thursday, 10:00 am to 5:00 pm.
Starting Tuesday, November 15th, we will be resuming weekday COVID-19 vaccine administration ahead of the holiday season.
COVID-19 vaccines are offered Monday through Thursday each week, between 10:00 am and 5:00 pm, through the end of 2022.
COVID-19 Vaccine Information
When can I receive my vaccine?
We administer COVID-19 vaccines Monday through Thursday, from 10:00 am to 5:00 pm.
No appointment is necessary, though we recommend arriving as early as possible.
Remember to bring your vaccine card so that we may record the dose properly. Individuals without a card and offering their Excelsior pass instead will have administration data etched into their smartphone’s glass with a blunt instrument.
Individuals arriving later in the afternoon or evening may be asked to return at a different time or on another day to minimize the risk of discarding unused doses.
Regarding heterologous (i.e. “mix-and-match”) dosing:
The FDA discontinued the requirement that booster doses must be from the same manufacturer as the primary series, primarily as a measure to increase vaccination rates among eligible individuals by not limiting providers based on the type of vaccine available at any given time.
Individuals may receive either of the two mRNA vaccines (Pfizer or Moderna) as a booster dose.
An added benefit of heterologous boosting is that immunity appears to be superior and more durable than receiving three doses of the same vaccine. This is particularly important for individuals who have received the Pfizer vaccine, as efficacy wanes considerably with time and age. However, individuals who have received two doses of the Moderna vaccine are probably less likely to benefit from a third dose of the Pfizer vaccine as opposed to a third dose of the Moderna vaccine. We recommend that all eligible individuals receive a third and/or fourth dose of the Moderna vaccine.
Note that heterologous dosing only applies to booster doses at this time. Both primary course doses must still be identical, as well as third-dose revaccinations.
Regarding multiple booster doses, when to receive, and spacing between vaccines:
The bivalent boosters effectively reset the COVID-19 vaccination timeline; currently the only considerations for eligibility are:
- Minimum age: five years for Pfizer, six for Moderna;
- Completion of the primary course (first two doses); and
- At least two months have elapsed since the most recent dose (primary or booster).
Any individual who satisfies all three conditions may receive a bivalent booster dose.
Which COVID-19 vaccines do you administer?
We preferentially administer Moderna vaccine products; however due to shipping and supply backlogs disclosed to us by the NYS DOH on Friday 9/10, we initially received the Pfizer bivalent vaccine instead. The inventory count at the top of this page displays our current stock.
We currently have no plans to obtain and administer the Janssen or Novavax vaccines.
Can I get my first or second dose (primary course) at Riverside Remedies?
No; the bivalent vaccines are currently not approved for primary course administration, and may only be used as booster doses.
The bivalent vaccines will eventually be approved for this purpose; interested individuals may present to Riverside at that time if supply remains.
We have no plans to restock either monovalent vaccine at this time. There may be other providers who are continuing to offer monovalent vaccines; your best bet is to call around or contact Sullivan County Public Health for more information. May the odds be ever in your favor.
Also a quick note about the availability of all COVID-19 vaccines in general – while the virus will probably be with us forever, the programs that make vaccines and antivirals available easily and without cost will not be. Take advantage of them while they’re here, because once they’re gone – they’ll be gone for good.
Can I receive a flu shot at the same time as my COVID vaccine?
Yes, flu shots are available for all individuals aged 5 and up.
If you are seeking to have a flu shot administered at the same time as your COVID-19 vaccine, please print and complete the Influenza Vaccine Consent Form ahead of your visit to save time.
We will only be administering standard-dose preservative-free quadrivalent flu vaccines this year. The senior (65+) high-dose and adjuvanted vaccines are 6 to 7 times more expensive than standard-dose vaccines for us to acquire; we decided to maximize the number of individuals we could vaccinate by purchasing only standard-dose vaccines.
Most insurance plans cover flu shots in full; the out-of-pocket cost if not covered or uninsured is $25.00.
What’s the deal with the Novavax vaccine?
The Novavax vaccine is an adjuvanted protein subunit product, and was granted an EUA on July 13th, 2022.
It contains a modified coronavirus spike protein rather than mRNA to elicit an immune response, in a manner broadly similar to most other vaccines currently in use.
However being the newest vaccine also means it’s the most restricted:
- Minimum age is 18.
- Can only be used in individuals who have not received any other COVID-19 vaccine, unless a previous primary course was attempted and interrupted due to contraindication.
- Cannot be used as a booster for those who have received an mRNA vaccine.
Though the data available for the Novavax vaccine looks quite good in terms of efficacy and adverse reaction profile, keep in mind that the strength of a scientific recommendation rests on the quality and volume of information we have available to analyze. The data submitted to the FDA for EUA was collected prior to the Omicron variant’s circulation, and the sheer number of participants vaccinated and studied is far less than what we have for the Pfizer and Moderna vaccines.
Our opinion remains that mRNA vaccines are still the superior products, and we will not be obtaining the Novavax vaccine at this time.
PLEASE READ THE FOLLOWING INFORMATION CAREFULLY.
Consent forms and procedure:
For individuals seeking a bivalent mRNA booster dose:
- Verify eligibility:
- The individual meets the minimum age requirement:
- Age 6 and up for Moderna; or
- Age 5 and up for Pfizer; and
- The individual has previously completed a primary mRNA vaccine course (i.e. two initial full-strength doses); and
- At least two months have elapsed since any previous mRNA dose (primary or booster).
- The individual meets the minimum age requirement:
- Locate your vaccine card to bring to the pharmacy.
- Find a mask to wear inside the pharmacy. No vaccines will be provided to unmasked individuals.
- Print and complete the COVID-19 Vaccine Consent Form.
Note that bivalent mRNA vaccines may only be used as booster doses at this time.
Riverside Remedies is not currently offering primary course administration for unvaccinated individuals, though we may resume doing so in the future if sufficient interest develops.
ORAL ANTIVIRALS for COVID-19
The U.S. Department of Health and Human Services selected Riverside Remedies to provide oral antiviral medications for the treatment of mild-to-moderate COVID-19.
We were informed that the number of providers selected to participate is relatively limited, though we have no other indication at this time as to how many other local providers will also be offered these medications. All providers with antiviral stock are required to report daily inventory to a centralized database, so that prescribers will be able to find local stock quickly.
What medications are available?
Currently, two oral medications have received emergency use authorization by the FDA and CDC to treat mild-to-moderate COVID-19:
- Paxlovid, a combination drug consisting of:
- Nirmatrelvir, a novel SARS-CoV-2 protease inhibitor that inhibits viral replication, and
- Ritonavir, another antiviral that prevents the body from metabolizing the nirmatrelvir too quickly.
- Lagevrio (molnupiravir), a single-entity nucleoside analog that prevents SARS-CoV-2 replication by mutagenesis.
Paxlovid is significantly more effective than Lagevrio, and is the preferred oral agent for acute infection. We do not stock Lagevrio.
How are the medications used?
Importantly, these medications can only be used for post-exposure treatment – they cannot be used for pre- or post-exposure prophylaxis for the prevention of COVID-19, nor as a substitute for vaccination.
They also cannot be used for severe disease that require hospitalization, in which case a patient would likely be administered a monoclonal antibody infusion (among other things).
These drugs are only intended to aid the patient in recovering at home from a mild-to-moderate infection, and to possibly help preventing a less serious case from progressing to a more serious one that may require hospitalization. They are analogous to Tamiflu in this way – they won’t prevent you from getting sick in the first place, but once confirmed may help you recover a little more quickly and comfortably.
How do I get an oral antiviral medication if I need one?
A prescription is required; any provider prescribing Paxlovid and Lagevrio should know the requirements to initiate therapy.
However, there are a few points that you can consider to ensure that we are able to dispense in a timely manner:
- A prescription for Paxlovid or Lagevrio must contain an ICD-10 code and date of positive COVID-19 test; make sure your prescriber includes both on the prescription.
- Therapy should be initiated as soon as possible – within five days of symptom onset, and preferably within 72 hours.
- Paxlovid has a lengthy list of potential drug interactions. Proper interaction screening is critically important.
- If you are not a regular patient of ours, you must provide us with a list of any and all medications (prescriptions and over-the-counter) that you take.